Disease: Acromegaly
- "Micromegaly": Acromegaly with apparently normal GH, an entity on its own?
- A Potent Neutralizing Monoclonal Antibody to Human Growth Hormone Suppresses Insulin-Like Growth Factor-1 in Female Rats
- A Rare Case When Acromegaly Meets Cushing Syndrome
- Acromegalic Rat Model Presented Cognitive Impairments and Tau Hyperphosphorylation in Hippocampus
- Acromegaly among a Moroccan population
- Acromegaly and Bone: An Update
- Acromegaly Type 1: A Representative Patient
- Acromegaly, Herniation of Cerebellar Tonsils, and Arnold-Chiari 1 Malformation: The Importance of Right Definitions
- Acromegaly: Overview and associated temporomandibular joint disorders
- ACROMORFO study: gait analysis in a cohort of acromegalic patients
- Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas
- Angioid Streaks
- Artificial intelligence in paediatric endocrinology: conflict or cooperation
- Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis
- Automated anatomical landmark detection on 3D facial images using U-NET-based deep learning algorithm
- Beware of epistaxis: fatal pseudoaneurysm rupture 30 years after treatment of acromegaly
- Carotid pseudoaneurysms after endoscopic transsphenoidal surgery for acromegaly
- Case report: First isolation of <em>Yersinia pseudotuberculosis</em> from the blood of a cat
- Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism
- Challenges of insulin-like growth factor-1 testing
- Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study
- Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades
- Clinicopathological Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology
- Connexin 36 Mediated Intercellular Endoplasmic Reticulum Stress Transmission Induces SSTA Resistance in Growth Hormone Pituitary Adenoma
- Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases
- Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
- Current role of pasireotide in the treatment of acromegaly
- Differences between GH and PRL co-secreting and GH-secreting pituitary adenomas. A series of 604 cases
- Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy
- Double pituitary adenomas: report of two cases and systematic review of the literature
- Double pituitary neuroendocrine tumors in a patient with normal growth hormone level acromegaly: A case report and review of the literature
- Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases
- Editorial: Treatment outcomes, comorbidities and impact of discordant biochemical values in acromegaly
- Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study
- Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study
- Empty sella in somatotropic pituitary adenomas; a series of 23 cases
- Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly
- Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis
- Feline Comorbidities: Hypersomatotropism-induced diabetes in cats
- Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine
- Genetic diagnosis in acromegaly and gigantism: From research to clinical practice
- GH and prolactin co-secreting adenomas: it is time for a definition
- Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test
- High mortality risk among women with acromegaly still persists
- Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives
- Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly
- Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016
- Investigational drugs for the treatment of acromegaly: new agents to transform therapy
- KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas
- Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives
- Long-term depot specific changes in adipose tissue after treatment of acromegaly
- Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center
- Machine learning-based algorithms applied to drug prescriptions and other healthcare services in the Sicilian claims database to identify acromegaly as a model for the earlier diagnosis of rare diseases
- Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts' consensus statement
- Multi-omics Investigations in Endocrine Systems and Their Clinical Implications
- Navigating the Surgical Landscape: A Comprehensive Analysis of Endoscopic vs. Microscopic Transsphenoidal Pituitary Surgery Outcomes
- New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases
- Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs
- Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma
- Pituitary Adenoma Prevalence and Characteristics of Omani Patients: A Single Center Experience
- Plurihormonal Pituitary Neuroendocrine Tumors: Clinical Relevance of Immunohistochemical Analysis
- Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study
- Predictors of biochemical response to somatostatin receptor ligands in acromegaly
- Preface to the Special issue: Diagnosis and treatment of acromegaly, a paradigmatic disease
- Preferences for different treatment options among people living with acromegaly in the US
- Pregnancy and acromegaly: clinical outcomes of retrospectively analysed data from the German acromegaly registry
- Profiling of Unfolded Protein Response Markers and Effect of IRE1α-specific Inhibitor in Pituitary Neuroendocrine Tumor
- Proteomics for the identification of peripheral markers in pituitary disease
- Pseudoacromegaly-A challenging entity in the endocrine clinic: A systematic review
- Quality of life in Prolactinoma: A systematic review
- Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up
- Real-world experience with 11C-methionine PET in the management of acromegaly
- Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly
- Real-world value of cabergoline in the treatment of acromegaly
- Recurrence in acromegaly: two tertiary centers experience and review of the literature
- Recurrent acromegaly: a systematic review on therapeutic approaches
- Recurrent, polycystic myxoma in a Carney complex patient undergoing medical control of acromegaly
- Role of IL33 in chronic inflammation and microvascular damage as a reflection of organ damage on a cohort of patients with acromegaly
- Skeletal Muscle Evaluation in Patients With Acromegaly
- Successful medical management of a pituitary macroadenoma with features of resistant acromegaly and hyperprolactinemia using pasireotide
- Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery
- Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop
- Tall stature and gigantism in adult patients with acromegaly
- The changing landscape of acromegaly - an epidemiological perspective
- The clinical and biochemical spectrum of ectopic acromegaly
- The effect of coping strategies on health-related quality of life in acromegaly patients
- The Effect of Metformin Treatment on Disease Control in Patients with Acromegaly
- The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin
- The Heart's Function as a Pump Assessed via Impedance Cardiography and the Autonomic System Balance in Patients with Early-Stage Acromegaly
- The molecular biology of sporadic acromegaly
- The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
- The RAPID Consortium: A Platform for Clinical and Translational Pituitary Tumor Research
- The spectrum of growth hormone excess in Carney complex and genotype-phenotype correlations
- Thyroid Disorders in Saudi Patients With Acromegaly: A Tertiary Care Center Experience
- Treatment of acromegaly with oral octreotide
- Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice
- Unravelling pituitary tumours in medically treated patients with acromegaly: the impact of systematic MRI reassessment
- Uric Acid Metabolic Disorders in Pituitary-Target Gland Axis
- Uterine fibroids in women diagnosed with acromegaly: a systematic review
- Validity of galactin-3 in acromegaly: comparison with traditional markers